CTRI/2024/03/064200
Not yet recruiting
Phase 2
An Open-label, single-arm clinical trial to evaluate Efficacy and Safety of Hariras Ayurvedic pills for symptomatic relief of acute nonproductive Cough and Throat Irritation - NI
Sushrutkrupa Ayurvedic Pharmacy Pvt. Ltd.0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: J09-J18- Influenza and pneumonia
- Sponsor
- Sushrutkrupa Ayurvedic Pharmacy Pvt. Ltd.
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Male and female subjects (18 to 65 years of age) with history of acute nonproductive cough and throat irritation for less than 1week duration
- •2\. Subjects with a cough score of 0, 1, or 2 during daytime
- •3\. Subjects willing and able to provide signed informed consent forms before any study\-related procedures.
- •4\. Subjects willing to abstain from other medication (allopathic or herbal) for cough treatment during the study period
- •5\. Subjects who in the opinion of the Investigator will be able to comply with the study requirements
Exclusion Criteria
- •1\. Subjects with a history of lower respiratory tract infections such as Pneumonia, Tuberculosis, Bronchitis, and Whooping cough.
- •2\. Subjects with a history of Chronic Obstructive Pulmonary Diseases, Asthma
- •3\. Subjects with a history of underlying lung pathology such as lung abscess, or cystic fibrosis.
- •4\. Subjects with known hypersensitivity to any ingredients of the investigational products
- •5\. Subjects with clinical suspicion of any systemic bacterial infection.
- •6\. Subjects with a history of Myocardial Infarction (MI) within 4 weeks before enrollment
- •7\. Subjects with immediate life\-threatening diseases such as pre\-existing cardiovascular, liver or neoplastic disease.
- •8\. Subjects who had received any sedative, hypnotic or tranquilizer within 14 days before randomization
- •9\. Subjects who had received any of the anti\-histamines, cough suppressants, mucolytics, expectorants, or antibiotics within 3 days before randomization.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
To know the effect of Rumalaya cream in common muscular paiHealth Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissueCTRI/2021/11/038256Himalaya Wellness Company
Active, not recruiting
Phase 3
A Japanese phase III multicenter, single-arm, open-label clinical trial to assess the efficacy and safety of the diagnosis/treatment of lymphedema by ICG fluorescent lymphangiography in patients with secondary lymphedemaJPRN-jRCT2031190064Akita Shinsuke50
Not yet recruiting
Not Applicable
A Clinical trial of Malbet syrup in pediatric patients with uncomplicated influenza.Health Condition 1: J118- Influenza due to unidentified influenza virus with other manifestationsCTRI/2023/10/058221Solar Herbo Pvt. Ltd.
Not yet recruiting
Phase 2
A study of tacrolimus lipid suspension in adult patients of allergic conjunctivitisHealth Condition 1: H104- Chronic conjunctivitisCTRI/2021/05/033314Intas Pharmaceuticals Ltd
Completed
Not Applicable
A clinical trial to study the effectiveness and safety of NEEMINT capsules in management of gastrointestinal disorders including Irritable bowel syndromeHealth Condition 1: K581- Irritable bowel syndrome with constipationHealth Condition 2: K580- Irritable bowel syndrome with diarrheaHealth Condition 3: K582- Mixed irritable bowel syndromeCTRI/2021/04/032735TRA GRACE15